Mark Lubberink
Professor at Department of Surgical Sciences; Molecular imaging and medical physics
- Telephone:
- +46 18 611 96 44
- Mobile phone:
- +46 70 867 61 64
- E-mail:
- mark.lubberink@uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 70, 1tr
- Postal address:
- Akademiska sjukhuset, ingång 70, 1tr
751 85 UPPSALA
More information is available to staff who log in.
Short presentation
This text is not available in English, therefore the Swedish version is shown.
My main research interest is quantitative PET methodology, especially aiming at clinical implementation of quantitative PET methods.
Biography
Mark Lubberink is professor of molecular imaging physics at Uppsala University. He studied technical physics at Eindhoven University of Technology in Eindhoven, The Netherlands and received his PhD from Uppsala University in 2001 with a thesis on quantitative PET with long-lived isotopes. After this, he worked as a post-doctoral researcher and medical physicist at the Department of Nuclear Medicine and PET Research at the VU University Medical Centre in Amsterdam. In 2010, he returned to Uppsala to work as senior medical physicist with PET, and has been head of the diagnostic medical physics group at Uppsala University Hospital since 2015. His main research interest is quantitative PET methodology, especially aiming at clinical implementation of quantitative PET methods.
Publications
Recent publications
- A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging. (2024)
- Determining Hemodynamically Significant Coronary Artery Disease (2024)
- Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system (2024)
- GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy (2024)
- Evaluation of [11C]UCB-A positron emission tomography in human brains (2024)
All publications
Articles
- A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging. (2024)
- Determining Hemodynamically Significant Coronary Artery Disease (2024)
- Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system (2024)
- GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy (2024)
- Evaluation of [11C]UCB-A positron emission tomography in human brains (2024)
- Impact of simulated reduced injected dose on the assessment of amyloid PET scans. (2024)
- Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer. (2023)
- In Vivo Visualization and Quantification of Neutrophil Elastase in Lungs of COVID-19 Patients (2023)
- Detection and correction of patient motion in dynamic 15O-water PET MPI. (2023)
- Acute nicotine exposure blocks aromatase in the limbic brain of healthy women (2023)
- Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression (2023)
- Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals (2023)
- Left ventricular volumes and ejection fraction from cardiac ECG-gated 15O-water positron emission tomography compared to cardiac magnetic resonance imaging using simultaneous hybrid PET/MR (2023)
- Influence of image reconstruction on quantitative cardiac 15O-water positron emission tomography (2023)
- First-in-human evaluation of [18F]CETO (2023)
- Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity (2023)
- Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction (2023)
- Application of positron emission tomography in psychiatry-methodological developments and future directions (2022)
- Dopamine and fear memory formation in the human amygdala (2022)
- Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy (2022)
- Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease (2022)
- Refined Analysis of Chronic White Matter Changes after Traumatic Brain Injury and Repeated Sports-Related Concussions (2022)
- Effect of PET-CT misalignment on the quantitative accuracy of cardiac 15O-water PET (2022)
- Influence of patient motion on quantitative accuracy in cardiac 15O-water positron emission tomography. (2022)
- Comparison of Ga-68-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer (2022)
- Composite attenuation correction method using a 68Ge-transmission multi-atlas for quantitative brain PET/MR. (2022)
- Diagnosis of left ventricular hypertrophy using non-ECG-gated 15O-water PET. (2022)
- Perspectives on translational molecular imaging and therapy (2022)
- Chronic cerebral blood flow alterations in traumatic brain injury and sports-related concussions (2022)
- Effects of Gastric Bypass Surgery on the Brain (2021)
- Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes (2021)
- Evaluation of Arterial Spin Labeling MRI (2021)
- 18Fluorodeoxyglucose uptake in relation to fat fraction and R2*in atherosclerotic plaques, using PET/MRI (2021)
- Assessment of myocardial viability with [15O]water PET (2021)
- Cardiac software repeatability beyond correlations (2021)
- Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder (2021)
- Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder (2021)
- Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE (2021)
- Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT (2021)
- Evaluation of quantitative CMR perfusion imaging by comparison with simultaneous 15O-water-PET (2021)
- Cerebral blood flow measurements with 15O-water PET using a non-invasive machine-learning-derived arterial input function (2021)
- Quantitative comparison of data-driven gating and external hardware gating for 18F-FDG PET-MRI in patients with esophageal tumors (2021)
- PET/MRI of glucose metabolic rate, lipid content and perfusion in human brown adipose tissue (2021)
- Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients – A PET/MR study (2021)
- Inhibitory and excitatory neurotransmitter systems in depressed and healthy (2021)
- EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging (2021)
- Prospective data-driven respiratory gating of [Ga-68]Ga-DOTATOC PET/CT (2021)
- Para-chloro-2-[18F]fluoroethyl-etomidate (2021)
- Procedural recommendations of cardiac PET/CT imaging (2021)
- Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT (2021)
- Harmonisation of PET/CT contrast recovery performance for brain studies (2021)
- Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer (2020)
- Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia (2020)
- Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using 68Ga-DOTATOC and 68Ga-DOTATATE. (2020)
- 177Lu-DOTATATE peptide receptor radionuclide therapy (2020)
- Quantification of aromatase binding in the female human brain using [11 C]cetrozole positron emission tomography. (2020)
- Quantification of (11)C-PIB kinetics in cardiac amyloidosis (2020)
- Guidelines for the content and format of PET brain data in publications and archives (2020)
- Evaluation of block-sequential regularized expectation maximization reconstruction of 68Ga-DOTATOC, 18F-fluoride, and 11C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner (2020)
- Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases (2020)
- [11C]5-Hydroxy-tryptophan model for quantitative assessment of in vivo serotonin biosynthesis, retention and degradation in the endocrine pancreas (2020)
- In vivo instability of 177Lu-DOTATATE during peptide receptor radionuclide therapy (2020)
- Positron emission tomography (O-15-water, C-11-acetate, C-11-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy (2020)
- Carbon Flux as a Measure of Prostate Cancer Aggressiveness (2020)
- Comparison of 68Ga-PSMA-11 PET/CT with 11C-acetate PET/CT in re-staging of prostate cancer relapse (2020)
- Diagnostic Accuracy of [11C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis (2020)
- Procedural recommendations of cardiac PET/CT imaging (2020)
- Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [11C]PE2I PET-MR brain imaging (2020)
- Estimating the cold-induced brown adipose tissue glucose uptake rate measured by 18F-FDG PET using infrared thermography and water-fat separated MRI (2019)
- Glucose metabolism in the brain in LMNB1-related autosomal dominant leukodystrophy. (2019)
- Synaptic vesicle protein 2A as a potential biomarker in synaptopathies (2019)
- EANM procedural guidelines for myocardial perfusion scintigraphy using cardiac-centered gamma cameras (2019)
- Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET (2019)
- Regularized reconstruction of digital time-of-flight Ga-68-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients (2019)
- PET med O-15-vatten påvisade myokardischemi där övrig utredning gick bet. (2019)
- Cerebral serotonin transporter measurements with [11C]DASB (2019)
- Localizing biochemical recurrence of prostate cancer using [68Ga]-PSMA-11 PET/CT and [11C]-acetate PET/CT (2019)
- Overeating saturated fat promotes fatty liver and ceramides compared to polyunsaturated fat (2019)
- Kinetic Analysis of the HER2-binding ABY-025 Affibody Using Dynamic PET in Patients with Metastatic Breast Cancer (2018)
- Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes (2018)
- Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia (2018)
- Z-score maps from low-dose 18F-FDG PET of the brain in neurodegenerative dementia. (2018)
- Non-invasive tri-modal visualisation via PET/SPECT/μCT of recombinant human bone morphogenetic protein-2 retention and associated bone regeneration (2018)
- Comparison of Ga-68-DOTATATE and Lu-177-DOTATATE kinetics in neuroendocrine tumors (2018)
- 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors (2018)
- Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System (2018)
- Blood Flow Dependence of Early [C-11]PE2I and [F-18]FE-PE2I PET SUVR Measurements Used In the Differential Diagnosis of Parkinsonian Disorders (2018)
- Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease measured with O-15-water PET (2018)
- Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. (2018)
- Flutemetamol and FDG Brain-PET Image Reconstruction Methods Affect Software-Aided Diagnosis in Patients with Neurodegenerative Diseases (2018)
- Regularized Reconstruction of Ga-68-PSMA Whole-Body Examinations Acquired on a Digital Time-of-Flight PET/CT Scanner (2018)
- Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations (2018)
- Differential diagnosis of patients with parkinsonian syndrome using multilinear regression to disease-specific C-11-PE2I-PET templates and classification tree learning (2018)
- Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits (2018)
- Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving 177Lu-DOTATATE therapy (2018)
- Image contrast of 177Lu-filled spheres as measured with a GE Discovery 670 CZT SPECT/CT system (2018)
- Quantitative accuracy of 15O-water cerebral blood flow images based on penalized likelihood reconstruction (2018)
- Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and 68Ge-transmission-based attenuation correction (2018)
- In-vivo stability of 177Lu-DOTATATE during peptide receptor radionuclide therapy (2018)
- Striatal Phosphodiesterase 10A and Medial Prefrontal Cortical Thickness in Patients with Schizophrenia (2017)
- Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia (2017)
- Glucose uptake in skeletal muscle, brain and visceral adipose tissue assessed with PET/MR strongly predicts whole body glucose uptake during hyperinsulinaemia (2017)
- [(11)C]5-Hydroxy-Tryptophan PET for Assessment of Islet Mass During Progression of Type 2 Diabetes (2017)
- Correlation between regional cerebral blood flow based on simultaneously acquired arterial spin labelling MRI and 15O-water-PET using zero-echo-time-based attenuation correction (2017)
- Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising (2017)
- Quantitative positron emission tomography in brain research (2017)
- Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System (2017)
- Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System (2017)
- Performance comparison of three commercially available PET systems (2017)
- Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE (2017)
- Low tracer availability of Ga-68-DOTATOC and Ga-68-DOTATATE in blood for patients with high SSTR density leads to non-linear correlation between SUV and K-i (2017)
- Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction. (2017)
- Tracer kinetic analysis of [C-11] Cetrozole as a PET tracer for aromatase in the human brain (2017)
- Quantitative myocardial blood flow imaging with integrated time-of-flight PET-MR (2017)
- Validation of an image derived input function estimation method on PET/MR (2017)
- Optimisation of penalized likelihood estimation reconstruction (Q.Clear) on a digital time-of-flight PET-CT scanner for four different PET tracers (2017)
- Optimisation of penalized likelihood estimation reconstruction on a digital time-of-flight PET-CT scanner for four different PET tracers (2017)
- Tracer kinetic analysis of the SV2A ligand 11C-UCBA as a PET marker for synaptic density in humans (2017)
- Quantitative assessment of synaptic density using the SV2A ligand C-11-UCBA in humans (2017)
- Effect of motion-induced PET-CT misalignment on cardiac function and myocardial blood flow measured using dynamic O-15-water PET (2017)
- Validation of an image-derived input function method for O-15-water PET/MR brain scans (2017)
- Automatic extraction of left ventricular mass and volumes using parametric images from non-ECG-gated 15O-water PET/CT (2017)
- Calculation of left ventricular volumes and ejection fraction from dynamic cardiac-gated 15O-water PET/CT (2017)
- Dynamic Imaging of Prostate Cancer with 11C-acetate PET/CT (2017)
- Gender-related differences in absorbed dose to risk organs in patients receiving Lu-177-Octreotate therapy (2017)
- Image quality measurements with 177Lu on a GE Discovery 670 CZT (2017)
- Is there a gender difference of absorbed dose to the risk organs in patients receiving 177Lu-Octreotate therapy? (2017)
- Blood Flow Quantitation by Positron Emission Tomography During Selective Antegrade Cerebral Perfusion (2017)
- Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET (2017)
- Repeatability of quantitative parameters of 18F-fluoride PET/CT and biochemical tumour and specific bone remodelling markers in prostate cancer bone metastases (2017)
- Feasibility of affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting (2016)
- Striatal Phosphodiesterase 10A and Thinning of the medial Prefrontal Cortex in Schizophrenia - a PET and MRI study (2016)
- Pancreatic perfusion and subsequent response to glucose in healthy individuals and patients with type 1 diabetes (2016)
- Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm (2016)
- [C-11]UCB-A, a novel PET tracer for synaptic vesicle protein 2 A (2016)
- Alterations in the serotonergic and substance P systems in posttraumatic stress disorder (2016)
- Use of 5-Hydroxytryptophan Labeled With Carbon 11 in Social Anxiety Disorder Reply (2016)
- Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder (2016)
- Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder (2016)
- Validation of true low-dose 18F-FDG PET of the brain (2016)
- Validation of true low-dose 18F-FDG PET of the brain (2016)
- Visual Assessment of Brain Perfusion MRI Scans in Dementia (2016)
- Partial volume correction of brain pet studies using iterative deconvolution in combination with hypr denoising (2016)
- Noninvasive Quantification of Myocardial C-11-Meta-Hydroxyephedrine Kinetics (2016)
- Spectral analysis of [18f]flutemetamol grey and white matter kinetics (2016)
- Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography (2016)
- Comparison of PET/CT and PET/MR-based Ga-68-DOTATOC standardized uptake values (2016)
- Supervised Cluster Analysis for Automatic Extraction of Reference Region in Dynamic [F-18]THK5317 PET (2016)
- Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. (2016)
- Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software (2016)
- Kinetic models for measuring P-glycoprotein function at the blood-brain barrier with Positron Emission Tomography (2016)
- Tracer kinetic analysis of [18f](s)-thk5117 as a pet tracer for tau pathology (2016)
- Feasibility of 68Ga-labeled Siglec-9 peptide for the imaging of acute lung inflammation (2016)
- Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients (2016)
- Validation of Zero-Echo Time PET-MR against stand-alone PET using dynamic dopamine transporter imaging (2016)
- Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT (2016)
- Dynamic scanning, kinetic modelling and parametric images reveal lung inflammation (2016)
- Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders (2015)
- Poster Session 2 (2015)
- Serotonin Synthesis and Reuptake in Social Anxiety Disorder (2015)
- Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder (2015)
- Use of a Single 11C-Meta-Hydroxyephedrine Scan for Assessing Flow-Innervation Mismatches in Patients with Ischemic Cardiomyopathy (2015)
- Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol. (2015)
- Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysis. (2015)
- Validation of parametric net influx rate images of Ga-68-DOTATOC and Ga-68-DOTATATE (2015)
- Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE (2015)
- Quantitative myocardial blood flow imaging with integrated time-of-flight PET-MR (2015)
- Non-invasive determination of HER2-expression in metastatic breast cancer by using Ga-68-ABY025 PET/CT. (2015)
- O-15-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases (2015)
- Calculation of left ventricular ejection fraction using cardiac gated parametric blood volume images from a dynamic 15O-water PET/CTscan (2015)
- Fractional contribution of extrapolations after 96 h in absorbed dose calculation to kidneys in 450 patients with neuroendocrine tumours receiving Lu-177-DOTATATE therapy (2015)
- Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - (2015)
- Accuracy of [Ga-68]ABY-025 PET/CT for determination of HER2-expression in metastatic breast cancer (2015)
- Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy. (2015)
- Rat organ distribution of [Lu-177]-DO3A-VS-Cys(40)-Exendin-4 for the estimation of human dosimetry (2015)
- Dosimetry of [Ga-68]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human (2015)
- 188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors (2014)
- Dosimetry of 68Ga and 177Lu labeled Exendin4-impact on feasibility of repeated PET imaging and radiotherapy (2014)
- Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient (2014)
- Effect of cardiac hybrid O-15-water PET/CT imaging on downstream referral for invasive coronary angiography and revascularization rate (2014)
- The Positron Emission Tomography ligand [11C]5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas (2014)
- Quantification of [(11)C]-meta-hydroxyephedrine uptake in human myocardium (2014)
- BMP-2 Induced bone regeneration visualized by PET and SPECT (2014)
- Discovery and Development of C-11-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain (2014)
- Radiation dosimetry and tracer kinetic analysis of Ga-68-ABY025 Affibody in breast cancer patients (2014)
- Tracer kinetic analysis of C-11-LuAE92686, a novel PET ligand for imaging of phosphodiesterase 10A (2014)
- Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs (2014)
- Validation of the quantitative accuracy of gated dynamic cardiac O-15-water PET (2014)
- Positron Emission Tomography imaging of the glucagon like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs (2014)
- Comparison of [68Ga]-DOTA-TOC and [68Ga]-DOTA-TATE (2014)
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the In-111-ABY-025 Affibody Molecule (2014)
- Measuring HER2-expression in metastatic breast cancer using 68Ga-ABY025 PET/CT (2014)
- Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE (2014)
- GMP compliant preparation of a (68)Gallium-labeled Affibody analogue for breast cancer patient examination (2014)
- Reproducibility of quantitative parameters of F-18-Fluoride PET/CT in prostate bone metastases (2014)
- In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET (2013)
- Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status (2013)
- Hybrid imaging using quantitative H2 15O PET and CT-based coronary angiography for the detection of coronary artery disease (2013)
- Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient (2013)
- The Relationship Between Anatomical and Functional Coronary Artery Disease Severity and Transmural Myocardial Blood Flow Distribution (2013)
- Functional Imaging of the Pancreatic Graft by Positron Emission Tomography (2013)
- Glucose metabolism in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms (2013)
- Validation of parametric methods for [(11)C]PE2I positron emission tomography (2013)
- Biological effective doses in 300 patients undergoing therapy with Lu-177-octreotate (2013)
- Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment (2013)
- Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors (2013)
- Toward Prediction of Efficacy of Chemotherapy (2013)
- Comparison of radiation dosimetry of [Ga-68]Ga-DOTA-TOC and [Ga-68]Ga-DOTA-TATE in patients affected by neuroendocrine tumours (2013)
- Diagnostic accuracy of quantitative H215O PET measurements of hyperemic myocardial blood flow versus coronary flow reserve for the detection of obstructive coronary artery disease (2012)
- Diagnostic accuracy of hybrid quantitative H215O PET/CT imaging for the detection of coronary artery disease (2012)
- Carotid artery intima media thickness, but not coronary artery calcium, predicts coronary vascular resistance in patients evaluated for coronary artery disease (2012)
- Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease (2012)
- Carotid artery intima-media thickness, but not coronary artery calcium, predicts coronary vascular resistance in patients evaluated for coronary artery disease (2012)
- Relative Cerbral Blood Flow Measurement using dynamic Flumazenil-PET may Replace Fluorodeoxyglucose-PET in Epilepsy Surgical Investigations (2012)
- Parametric imaging of myocardial viability using ¹⁵O-labelled water and PET/CT (2012)
- Lessons on Tumour Response (2012)
- Quantitative accuracy of parametric myocardial and tumour blood flow images based on HYPR-LR-filtered dynamic [O-15]water PET (2012)
- Parametric methods for [11C]PE2I positron emission tomography (2012)
- Effect of variations in cerebellum kinetics on robustness of [C-11]DASB parametric images (2012)
- Metal artifact reduction in 18F-fluoride-PET/CT data of prosthetic hip patients (2012)
- Validity of Simplified 3′-Deoxy-3′-[18F]Fluorothymidine Uptake Measures for Monitoring Response to Chemotherapy in Locally Advanced Breast Cancer (2012)
- Measurement of absolute cerebral blood flow during cardiopulmonary bypass and selective cerebral perfusion using [O-15]water and PET (2012)
- Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET (2012)
- Inter-observer variability of absorbed dose estimates to the kidney in patients with neuroendocrine tumours receiving Lu-177-Octreotate therapy (2012)
- No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds (2012)
- Blood-brain barrier P-glycoprotein function in Alzheimer's disease (2012)
- P-Glycoprotein Function at the Blood-Brain Barrier (2012)
- Reproducibility of quantitative (R)-[11C]verapamil studies (2012)
- Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients (2012)
- No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds (2012)
- Towards Prediction of Efficacy of Chemotherapy (2012)
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy (2012)
- Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men (2011)
- Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI (2011)
- Parametric Images of Myocardial Viability Using a Single 15O-H2O PET/CT Scan (2011)
- Quantitative imaging of I-124 and Y-86 with PET (2011)
- Myocardial Oxygen Extraction Fraction Measured Using Bolus Inhalation of O-15-Oxygen Gas and Dynamic PET (2011)
- Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation (2011)
- Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction (2011)
- Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury (2011)
- Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy (2011)
- Reappraisal of a single-tissue compartment model for estimation of myocardial oxygen consumption by [11C]acetate PET (2011)
- Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography (2011)
- Comment on Cho et al. (2011)
- Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography (2011)
- Quantification of the neurokinin 1 receptor ligand [¹¹C]R116301 (2011)
- Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension (2011)
- Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization (2011)
- Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension (2011)
- Liver fat content in type 2 diabetes (2010)
- Quantitative Parametric Perfusion Images Using 15O-Labeled Water and a Clinical PET/CT Scanner (2010)
- Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography (2003)
- Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography (2003)
- Positron emission tomography and radioimmunotargeting (1999)
- Positron emission tomography and radioimmunotargeting (1999)
- Changes in serotonin and dopamine transporter availability after combined treatment with escitalopram and cognitive-behavioral therapy in patients with social anxiety disorder
- Response expectancies shape the effect of SSRI treatment on serotonin and dopamine transporters in patients with social anxiety disorder
- Comparison of 68Ga-DOTATATE and 177Lu-DOTATATE kinetics in neuroendocrine tumors
- Penalized-likelihood reconstruction of [11C]metomidate PET in patients with primary aldosteronism
- Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate:a PET tracer for adrenocortical imaging
- Composite 68Ge attenuation correction for quantitative brain PET/MR
- Comparison of quantitative [11C]PE2I PET scans acquired on PET/MR and stand-alone PET
- Cerebral blood flow in multiple sclerosis: an 15O-water PET study
- Blood flow and metabolism during selective cerebral perfusion - a PET study